Prices delayed by at least 15 minutes | Print


Avacta Group PLC (AVCT)

ORD 10P
Sell: 47.5p|Buy: 48p|Change: 1.21 (-2.47%)

Open 

48.75p


Previous close 

49p


Trade high 

48.935p


Volume 

1,133,392


Year high 

166.98p


Year low 

47.33p


Dividend yield 

-


Market capitalisation 

£167.51 mn


P/E ratio 

-


ISIN 

GB00BYYW9G87


This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment

Share price

Performance 27/03/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Avacta Group PLC- 3.73
FTSE AIM 100+ 0.44
More...

Company profile

Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and precision tumor-targeted chemotherapy. The company operates in the United Kingdom, France, South Korea, Rest of Europe, Asia, and North America.

Sector 

Healthcare


News

Recent trades

DateTimePriceQuantityValue (£)
28/03/202410:56:0747.7910,4374,987.84
28/03/202410:52:0847.62,1141,006.26
28/03/202410:49:5347.82,069988.98
28/03/202410:47:4647.81,037495.69
28/03/202410:44:3947.81,566748.55

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.